REGISTER FOR TESTING
ACCESS REPORTS


REGISTER
FOR TESTING

ACCESS REPORTS
REGISTER FOR TESTING
ACCESS REPORTS

REGISTER
FOR TESTING

ACCESS
REPORTS

Comprehensive Alzheimer's Disease Biomarker Testing

At MusB Diagnostics, we provide advanced biomarker testing for Alzheimer’s disease, offering early detection and disease progression insights. Our specialized assays analyze key neurodegenerative markers, helping healthcare providers make informed diagnostic and treatment decisions.

🔹 Advanced Alzheimer's Diagnostics for Better Outcomes

Early identification of Alzheimer's risk and disease progression
Comprehensive biomarker testing for targeted patient care
Accurate differentiation between Alzheimer's and other dementias
Fast, reliable results for proactive treatment planning

🔹 Key Alzheimer's Biomarkers*

p-Tau217 (Phosphorylated Tau 217): Highly specific for Alzheimer’s pathology and disease progression
NfL (Neurofilament Light Chain):Marker for neurodegeneration and axonal damage in Alzheimer’s, ALS, and other brain disorders
β-Amyloid 1–42:Essential for Alzheimer’s diagnosis, associated with amyloid plaque formation in the brain
GFAP (Glial Fibrillary Acidic Protein):Measures neuroinflammation and astrocyte activation, aiding in early-stage detection
APOE ε4 (Apolipoprotein E ε4):Genetic risk factor for Alzheimer’s disease, associated with increased amyloid accumulation

MusB Diagnostics—leading the way in Alzheimer’s biomarker testing for early intervention and better patient care.

*Assays in development. For Research Use Only. Not for use in Diagnostic Procedures. (FINE PRINT)
image_2025_02_22T04_35_46_507Z

Advanced Alzheimer's Diagnostics for Better Outcomes

Early identification of Alzheimer's risk and disease progression
Comprehensive biomarker testing for targeted patient care
Accurate differentiation between Alzheimer's and other dementias
Fast, reliable results for proactive treatment planning
99% accurate results within 24-72 hours
Early detection of Alzheimer's and neurodegenerative conditions
Precision-driven testing for personalized disease management

Key Alzheimer's Biomarkers*

p-Tau217 (Phosphorylated Tau 217): Highly specific for Alzheimer’s pathology and disease progression
NfL (Neurofilament Light Chain):Marker for neurodegeneration and axonal damage in Alzheimer’s, ALS, and other brain disorders
β-Amyloid 1–42:Essential for Alzheimer’s diagnosis, associated with amyloid plaque formation in the brain
GFAP (Glial Fibrillary Acidic Protein):Measures neuroinflammation and astrocyte activation, aiding in early-stage detection
APOE ε4 (Apolipoprotein E ε4):Genetic risk factor for Alzheimer’s disease, associated with increased amyloid accumulation

MusB Diagnostics—leading the way in Alzheimer’s biomarker testing for early intervention and better patient care.

*Assays in development. For Research Use Only. Not for use in Diagnostic Procedures.

QUICK LINKS

(813) 419-0781

info@musbdiagnostics.com

6331 State Road 54, New Port Richey,
FL 34653

Email: info@musbdiagnostics.com

Address : 6331 State Road 54, New Port Richey,
FL 34653

Facebook-f X-twitter Instagram Linkedin-in

@ 2025. MusB Diagnostics- All Rights Reserved